Survey Reveals Critical Gap in Patient Engagement Across Clinical Trial Industry
• A comprehensive industry survey shows that 41% of pharmaceutical companies and CROs do not collect patient feedback at all, highlighting a significant gap in clinical trial engagement practices.
• Despite growing evidence of benefits, patient engagement remains underfunded, with 26% of companies citing budget constraints as the primary barrier to implementing engagement initiatives.
• Traditional face-to-face and phone interactions prove most effective for patient retention, while ROI from digital health technologies remains uncertain with 43% of respondents unsure of their value.
© Copyright 2025. All Rights Reserved by MedPath